Comparison of a new orally potent tripeptide HIV-1 protease inhibitor (anti-aids drug) based on pharmacokinetic characteristics in rats after intravenous and intraduodenal administrations

This publication has 9 references indexed in Scilit:

• In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine
  Antimicrobial Agents and Chemotherapy, 1993
• Pharmacokinetic study of a tripeptide HIV‐1 protease inhibitor, KNI‐174, in rats after intravenous and intraduodenal administrations
  Biopharmaceutics & Drug Disposition, 1993
• The HIV-1 Protease as a Therapeutic Target for AIDS
  AIDS Research and Human Retroviruses, 1992
• Kynostatin (KNI-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
• Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease
  Antimicrobial Agents and Chemotherapy, 1991
• HIV protease: a novel chemotherapeutic target for AIDS
  Journal of Medicinal Chemistry, 1991
• Human immunodeficiency virus protease: A target for aids therapy
  Drug Development Research, 1990
• Renin Inhibitors
  Pharmaceutical Research, 1987
• Analog approaches to the structure of the transition state in enzyme reactions
  Accounts of Chemical Research, 1972